neurocardiogenic vasopressor dysfunction; neurally-mediated syncope; reflex syncope (NVD)

From Aaushi
Jump to navigation Jump to search

Classification

Etiology

Epidemiology

  • accounts for the majority of syncopal episodes in the general population

Pathology

Clinical manifestations

Diagnostic procedures

Management

More general terms

More specific terms

References

  1. 1.0 1.1 Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 204
  2. 2.0 2.1 Sheldon R et al, Prevention of Syncope Trial (POST): A randomized, placebo- controlled study of metoprolol in the prevention of vasovagal syncope Circulation 2006; 113:1164 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16505178
  3. 3.0 3.1 3.2 3.3 Medical Knowledge Self Assessment Program (MKSAP) 14, 16. American College of Physicians, Philadelphia 2006, 2012
  4. Duplyakov D, Golovina G, Garkina S, Lyukshina N. Is it possible to accurately differentiate neurocardiogenic syncope from epilepsy? Cardiol J. 2010;17(4):420-7. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20690104
  5. 5.0 5.1 Sheldon R, Raj SR, Rose MS et al Fludrocortisone for the Prevention of Vasovagal Syncope. A Randomized, Placebo-Controlled Trial. J Am Coll Cardiol. 2016;68(1):1-9. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27364043 <Internet> http://content.onlinejacc.org/article.aspx?articleid=2530086
    Brignole M Finally, a Drug Proves to Be Effective Against Vasovagal Syncope! But Not in All Patients. J Am Coll Cardiol. 2016;68(1):10-12 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27364044 <Internet> http://content.onlinejacc.org/article.aspx?articleid=2530082
  6. 6.0 6.1 Geriatric Review Syllabus, 10th edition (GRS10) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2019